BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28395442)

  • 1. [PD-1/PD-L1 expression and its implications in patients with chronic lymphocytic leukemia].
    Li JH; Pang NN; Zhang ZH; Zhang R; Chen G; Qu JH
    Zhonghua Xue Ye Xue Za Zhi; 2017 Mar; 38(3):198-203. PubMed ID: 28395442
    [No Abstract]   [Full Text] [Related]  

  • 2. PD-1 and PD-L1 gene expressions and their association with Epstein-Barr virus infection in chronic lymphocytic leukemia.
    Gamaleldin MA; Ghallab OM; Nadwan EA; Abo Elwafa RA
    Clin Transl Oncol; 2021 Nov; 23(11):2309-2322. PubMed ID: 34120295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Gooden CE; Jones P; Bates R; Shallenberger WM; Surti U; Swerdlow SH; Roth CG
    Cytometry B Clin Cytom; 2018 Jan; 94(1):129-135. PubMed ID: 27221715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of CLLU1 in patients with chronic lymphocytic leukemia and its prognostic significance].
    Chen LJ; Zheng WJ; Wu YJ; Li L; Qian SX; Xu W; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):737-40. PubMed ID: 18457263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ZAP-70 expression in 24 patients with B cell chronic lymphocytic leukemia].
    Wu YJ; Li JY; Zhu GR; Song JH; Xiao B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):237-40. PubMed ID: 16638188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. THE PROGNOSTIC SIGNIFICANCE OF COMBAIND EXPRESSION OF ZAP-70 AND CD38 IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Kirtava T; Vatsadze T; Azrmaiparashili E; Ghirdaladze D
    Georgian Med News; 2017 Jun; (267):12-16. PubMed ID: 28726646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia.
    Chen L; Li J; Zheng W; Zhang Y; Wu Y; Li L; Qian S; Xu W
    Leuk Lymphoma; 2007 Sep; 48(9):1785-92. PubMed ID: 17786715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
    Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.
    Hüttmann A; Klein-Hitpass L; Thomale J; Deenen R; Carpinteiro A; Nückel H; Ebeling P; Führer A; Edelmann J; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2006 Oct; 20(10):1774-82. PubMed ID: 16932341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The study of different chromosomal aberrations, CD38 and ZAP-70 in chronic lymphocytic leukemia patients.
    Hassab AH; Elbordiny MM; Elghandour AH; Sorour AF; Swelem RS
    Egypt J Immunol; 2011; 18(2):77-93. PubMed ID: 23082473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zeta-associated protein 70 expression in chronic lymphocytic leukemia: Relevance in Indian context.
    Gupta R; Garg N; Singh A; Jain SL
    Indian J Pathol Microbiol; 2023; 66(2):291-294. PubMed ID: 37077070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic significance of new biological markers in chronic lymphocytic leukaemia].
    Leković D; Mihaljević B; Kraguljac-Kurtović N; Perunčić-Jovanović M; Bogdanović A; Čolović M; Gotić M
    Srp Arh Celok Lek; 2011; 139(11-12):753-8. PubMed ID: 22338471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
    Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
    Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia.
    Hus I; Podhorecka M; Bojarska-Junak A; Roliński J; Schmitt M; Sieklucka M; Wasik-Szczepanek E; Dmoszyńska A
    Ann Oncol; 2006 Apr; 17(4):683-90. PubMed ID: 16524977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
    Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of ZAP-70 expression in chronic lymphocytic leukemia: T/B-cell ratio of mean fluorescence intensity provides stronger prognostic value than percentage of positive cells.
    Smolej L; Vroblova V; Motyckova M; Jankovicova K; Schmitzova D; Krejsek J; Maly J
    Neoplasma; 2011; 58(2):140-5. PubMed ID: 21275464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia.
    Xu W; Li JY; Wu YJ; Yu H; Shen QD; Tian T; Li L; Qiu HX
    Leuk Res; 2009 Feb; 33(2):237-43. PubMed ID: 18674817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-L1
    Zacca ER; Onofrio LI; Acosta CDV; Ferrero PV; Alonso SM; Ramello MC; Mussano E; Onetti L; Cadile II; Stancich MI; Taboada Bonfanti MC; Montes CL; Acosta Rodríguez EV; Gruppi A
    Front Immunol; 2018; 9():2241. PubMed ID: 30327652
    [No Abstract]   [Full Text] [Related]  

  • 19. Elevated IL-17A and IL-22 regulate expression of inducible CD38 and Zap-70 in chronic lymphocytic leukemia.
    Kouzegaran S; Siroosbakht S; Farsad BF; Rezakhaniha B; Dormanesh B; Behnod V; Tanha AS
    Cytometry B Clin Cytom; 2018 Jan; 94(1):143-147. PubMed ID: 27718514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels.
    Rivkina A; Vitols G; Murovska M; Lejniece S
    Exp Oncol; 2011 Jun; 33(2):99-103. PubMed ID: 21716207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.